EXIMIAS Pharmaceutical Corp. acquires late stage pharmaceuticals for enhancement and marketing

History:

EXIMIAS Pharmaceutical was acquired by YM BioSciences in 2006.

Employment

Email:

Fax:

Mail:

General Info:

Ticker:

Employees:

Regions:
Other US

Research Focus:
Disease Therapeutics:Clinical late (III) Therapeutics-Marketing

 

Profiles:

 

News:

Keywords: 

Strategic Partnerships: